Code Snippets
curl "https://financialdata.net/api/v1/key-metrics?identifier=GILD&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/key-metrics?identifier=GILD&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/key-metrics?identifier=GILD&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "GILD",
"central_index_key": "0000882095",
"registrant_name": "GILEAD SCIENCES, INC.",
"fiscal_year": "2025",
"period_end_date": "2025-12-31",
"earnings_per_share": 6.84,
"earnings_per_share_forecast": -0.47,
"price_to_earnings_ratio": 17.9444444444444,
"forward_price_to_earnings_ratio": -261.148936170213,
"earnings_growth_rate": 1700.0,
"price_earnings_to_growth_ratio": 0.0105555555555556,
"book_value_per_share": 18.25,
"price_to_book_ratio": 6.72547945205479,
"ebitda": 15139000000.0,
"enterprise_value": 172868560000.0,
"dividend_yield": 0.026216764373179,
"dividend_payout_ratio": 0.470387779083431,
"debt_to_equity_ratio": 1.22204113993745,
"capital_expenditures": 2582000000.0,
"free_cash_flow": 7437000000.0,
"return_on_equity": 0.374840329471876,
"one_year_beta": 0.345040391052869,
"three_year_beta": 0.349431345773952,
"five_year_beta": 0.412782327633938
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security, or the central index key (CIK). The latter is assigned to the entity by the United States Securities and Exchange Commission. (e.g., MSFT, 0000789019) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
The API endpoint returns key financial metrics such as price-to-earnings ratio, price-to-book ratio, free cash flow, etc. This information is particularly important for value investors looking to identify undervalued stocks. Data is available for several thousand US and international companies.
Company Profile
GILEAD SCIENCES, INC.
NASDAQ: GILD- Market Cap:$103.20B
- ISIN:US3755581036
- Fiscal Year End:12/31
- CEO:Daniel O'Day
- Employees:17000
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
GILD Datasets
GILD Stock QuotesGILD Stock PricesGILD Minute PricesGILD Company InformationGILD Market CapGILD Employee CountGILD Executive CompensationGILD Income StatementsGILD Balance Sheet StatementsGILD Cash Flow StatementsGILD Insider TransactionsGILD Senate TradingGILD Institutional HoldingsGILD Analyst ConsensusGILD Earnings ReleasesGILD Stock SplitsGILD DividendsGILD Short Interest